Filsuvez

Active Ingredient(s): Birch Triterpenes
FDA Approved: * December 18, 2023
Pharm Company: * AMRYT
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Filsuvez 100 mg/g Topical Gel
NDC: 10122-310
Labeler:
Chiesi USA, Inc.
Filsuvez 100 mg/g Topical Gel
NDC: 76431-310
Labeler:
Amryt Pharmaceuticals Dac